Home / Healthcare professionals
  • The Raypilot Solution

    Enables Hypofractionated Accurate Radiotherapy

Raypilot offers accurate localization and tracking of prostate motion

Micropos Medical provides advanced technologies, powered by Artificial Intelligence (AI), with the potential to enhance the accuracy in radiotherapy of cancer.
The Raypilot HypoCath system includes a patented temporary transmitter, which tracks the prostate tumor movements and outlines the urethra in real-time 3D. This can facilitate hypofractionated radiation therapy, which allows physicians to reduce treatment margins to a minimum (sparing healthy tissue), while increasing the dose to the tumor for a more efficient outcome and providing optimized treatment opportunities.


Micropos årsstämma hölls igår den 24 maj i Göteborg.

Micropos årsstämma hölls igår onsdagen den 24 maj i Göteborg. Vi tackar alla medverkande för en trevlig stämma. Bolagets VD Thomas Lindström säger: -       Vi…

Read more

Kallelse till Årsstämma i Micropos Medical AB (publ)

Aktieägarna i Micropos Medical AB (publ) (”Bolaget”), 556648-2310, kallas härmed till årsstämma tisdag den 24 maj 2022 kl. 16.00, Hotel Waterfront Göteborg, Adolf Edelsvärds Gata…

Read more
See all news


The 2022 ASTRO Annual Meeting

We are very excited to visit the 64th ASTRO Annual Meeting in San Antonio, USA. Meeting Dates: October 23 - 26, 2022 Exhibit Dates: October 23 -…

Read more
See all upcoming events